Tell us what you think about Healio
Sign in for a personal experience.
Customized content served to meet your interests.
Prophylactic use of Factor VIII appeared to decrease inhibitor risk in a cohort of children with severe hemophilia A, study results showed.
Researchers conducted the investigation to evaluate links between treatment intensity and inhibitor incidence in a cohort of consecutive, previously untreated patients. Treatment intensity ranged from high-dosed intensive Factor VIII treatment to prophylactic therapy.
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.
View past polls
©2013 All Rights Reserved.